Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-001862-17Phase 3Active
Phase 3, randomised, double-blind trial in thromboembolism and Phlebothrombosis comparing Bemiparin bridging therapy with Calcium heparin bridging therapy (2 arms). Primary endpoint: Occurrence of thromboembolic events. Started Mar 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-001862-17.